Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05820087 · ClinicalTrials.gov registry record · NA
The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)
A NA study of Kidney Cancer and Renal Cancer, sponsored by HistoSonics.
- Active
- Registry status
- NA
- Development phase
- 67
- Enrollment target
- 15
- Study locations
NCT05820087: Active NA study of Kidney Cancer and Renal Cancer, sponsored by HistoSonics.
NCT05820087 is a NA study of Kidney Cancer and Renal Cancer that is active but no longer recruiting, run by HistoSonics. The registered enrollment target is 67 participants, below the 879-participant average among 60 other Kidney Cancer trials with a reported enrollment target (92% lower). The trial reports 15 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05820087, a NA study of Kidney Cancer and Renal Cancer, is active but no longer recruiting, sponsored by HistoSonics.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 67 participants
- Enrollment target
- 15
- Study locations
Study Summary
The purpose of this trial is to evaluate the effectiveness and safety of the HistoSonics Edison System for the destruction of kidney tissue by treating primary solid renal tumors.
Primary Outcome
Primary Effectiveness Endpoint
Conditions Studied
Interventions
- DEVICE HistoSonics Edison System
Study Locations (15)
New York
- Northwell Health - Lake Success
- NYU Langone Health - New York
- Icahn School of Medicine Mount Sinai - New York
- University of Rochester Medical Center - Rochester
California
- University of Southern California - Los Angeles
- University of California, Los Angeles (UCLA) - Los Angeles
- Providence Mission Hosptial - Mission Viejo
Connecticut
- Yale School of Medicine - New Haven
Florida
- AdventHealth Celebration - Celebration
Maryland
- Johns Hopkins University - Baltimore
Massachusetts
- Massachusetts General Hospital - Boston
Ohio
- The Ohio State University Comprehensive Cancer Center - Columbus
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 67 participants |
| Start Date | 2024-01-04 |
| Est. Completion | 2030-07 |
| Phase | NA |
What the registry record for NCT05820087 still lists
NCT05820087 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 879-participant average among 60 other Kidney Cancer trials with a reported enrollment target (92% lower).
The record links to 5 conditions, with Kidney Cancer appearing as the primary indexed condition, and to 1 intervention - of which HistoSonics Edison System is the first listed.
NCT05820087 lists 15 locations in 10 states (New York, California, Connecticut).
Frequently Asked Questions
What is clinical trial NCT05820087 about?
NCT05820087 is a clinical study titled "The HistoSonics Edison™ System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY)". The purpose of this trial is to evaluate the effectiveness and safety of the HistoSonics Edison System for the destruction of kidney tissue by treating primary solid renal tumors.
What is the current status of trial NCT05820087?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 67 participants. The study started on 2024-01-04. Estimated completion is 2030-07.
What conditions does trial NCT05820087 study?
This clinical trial studies the following conditions: Kidney Cancer, Renal Cancer, Tumor, Tumor, Solid, Tumor, Benign.
What interventions are being tested in trial NCT05820087?
The interventions under investigation include: HistoSonics Edison System (DEVICE).
Who is sponsoring clinical trial NCT05820087?
This trial is sponsored by HistoSonics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05820087 being conducted?
This trial has 15 study locations across California, Connecticut, Florida, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05820087's enrollment target sits among peer trials
67 29th of 60 higher than 32 of 60 other Kidney Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
RECRUITING · NA
-
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
RECRUITING · NA
-
Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)
RECRUITING · NA
-
A Novel Imaging Protocol in Use to Identify Lymph Nodes and Organs of Interest
RECRUITING · NA
-
Designing Visual Tools to Enhance Cancer Surgeon Decision-making
RECRUITING · NA
-
Integrated Actionable Aging Assessment for Cancer Patients Pilot
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03213002 · 67 participants · Phase 1
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM
- NCT04115163 · 67 participants · Phase 2
Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer
- NCT04315324 · 67 participants · Phase 1
Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)
- NCT04532424 · 67 participants · NA
Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI